India cuts cancer drug prices after court ruling on mark-ups
India has lowered the cost of cancer drugs. The move follows a court ruling that called the high mark-ups extortion.
पार्श्वभूमीCancer drugs are often expensive, and India's drug pricing is regulated by the government through a national list of essential medicines. Courts have stepped in before to question high prices, and pricing disputes over medicines are a recurring issue in the country's healthcare debate.
The Guardian वर वाचा (इंग्रजी)
बर्निंग पोटॅटो स्कोअर: 52%